APA (7th ed.) Citation

A, M., O, M., B, L., C, G., VR, R., F, C., . . . M, W. (2025). Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma. The Journal of investigative dermatology, 145(4), 979. https://doi.org/10.1016/j.jid.2024.07.037

Chicago Style (17th ed.) Citation

A, Méant, et al. "Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma." The Journal of Investigative Dermatology 145, no. 4 (2025): 979. https://doi.org/10.1016/j.jid.2024.07.037.

MLA (9th ed.) Citation

A, Méant, et al. "Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma." The Journal of Investigative Dermatology, vol. 145, no. 4, 2025, p. 979, https://doi.org/10.1016/j.jid.2024.07.037.